Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
26/05/2020 10:28:14
Exchange Disseminated Time
26/05/2020 10:28:16
Time Taken
00:00:02
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
5/26/2020 10:28:15 AM
Glenmark to commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India
Attachment
<< Back
Recently Viewed